IL-6 positively regulates Foxp3+CD8+ T cells in vivo
Author(s) -
Takayuki Nakagawa,
Mineko Tsuruoka,
Hideki Ogura,
Yuko Okuyama,
Yasunobu Arima,
Toshio Hirano,
Masaaki Murakami
Publication year - 2009
Publication title -
international immunology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.86
H-Index - 134
eISSN - 1460-2377
pISSN - 0953-8178
DOI - 10.1093/intimm/dxp119
Subject(s) - foxp3 , cd8 , in vivo , inflammation , immunology , t cell , cytotoxic t cell , tcirg1 , microbiology and biotechnology , arthritis , chemistry , biology , cancer research , interleukin 21 , in vitro , immune system , biochemistry
Although recent studies have identified regulatory roles for Foxp3(+)CD8(+) T cells, the mechanisms that induce their development and underlie their functions in vivo have not been elucidated. Here, we show that IL-6 positively regulates the Foxp3(+)CD8(+) T-cell development and function. The Foxp3(+)CD8(+) T cells that differentiated in vitro in the presence of IL-6 suppressed autoimmune colitis and arthritis in vivo. Moreover, Foxp3(+)CD8(+) T cells that developed in vivo in the presence of enhanced IL-6 signaling suppressed the development of a spontaneous T(h)17 cell-mediated autoimmune arthritis. Thus, we concluded that Foxp3(+)CD8(+) T cells develop in response to IL-6 and regulate chronic inflammation in T(h)17 cell-mediated F759 autoimmune arthritis. These results suggested that Foxp3(+)CD8(+) T cells may develop in response to IL-6 under certain inflammatory conditions in vivo and may regulate some other chronic inflammation diseases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom